SEC Form 4 · accession 0001140361-15-041923
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Pendarvis
Officer — Chief Administrative Officer
Period of report
Nov 12, 2015
Accepted (ET)
Nov 16, 2015 · 8:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | Nov 12, 2015 | M | 3,625 | $27.58 | A | 74,287 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock Options | $27.58 | Nov 12, 2015 | M | 3,625 | D | Nov 11, 2015 | Nov 16, 2018 | ResMed Common Stock | 3,625 | 0 | D |